Literature DB >> 24948381

Looking ahead: electroretinographic anomalies, glycogen synthase kinase-3, and biomarkers for neuropsychiatric disorders.

Guang Chen1, Ioline D Henter2, Husseini K Manji3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24948381      PMCID： PMC4175717          DOI： 10.1016/j.biopsych.2014.05.005

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  10 in total

Review 1.  Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

2.  A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors.

Authors:  Jing Du; Yanling Wei; Lidong Liu; Yun Wang; Rushaniya Khairova; Rayah Blumenthal; Tyson Tragon; Joshua G Hunsberger; Rodrigo Machado-Vieira; Wayne Drevets; Yu Tian Wang; Husseini K Manji
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

Review 3.  GSK3 signalling in neural development.

Authors:  Eun-Mi Hur; Feng-Quan Zhou
Journal:  Nat Rev Neurosci       Date:  2010-08       Impact factor: 34.870

4.  Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice.

Authors:  E Beurel; L Song; R S Jope
Journal:  Mol Psychiatry       Date:  2011-04-19       Impact factor: 15.992

Review 5.  Is glycogen synthase kinase-3 a central modulator in mood regulation?

Authors:  Xiaohua Li; Richard S Jope
Journal:  Neuropsychopharmacology       Date:  2010-07-28       Impact factor: 7.853

6.  An emerging role for Wnt and GSK3 signaling pathways in schizophrenia.

Authors:  K K Singh
Journal:  Clin Genet       Date:  2013-04-01       Impact factor: 4.438

Review 7.  Targeting signal transduction pathways in the treatment of mood disorders: recent insights into the relevance of the Wnt pathway.

Authors:  Todd D Gould; Eliot R Dow; Kelley C O'Donnell; Guang Chen; Husseini K Manji
Journal:  CNS Neurol Disord Drug Targets       Date:  2007-06       Impact factor: 4.388

8.  Glycogen synthase kinase-3 overexpression replicates electroretinogram anomalies of offspring at high genetic risk for schizophrenia and bipolar disorder.

Authors:  Joëlle Lavoie; Marc Hébert; Jean-Martin Beaulieu
Journal:  Biol Psychiatry       Date:  2013-10-17       Impact factor: 13.382

9.  DISC1 partners with GSK3beta in neurogenesis.

Authors:  Guo-li Ming; Hongjun Song
Journal:  Cell       Date:  2009-03-20       Impact factor: 41.582

10.  GSK-3 and Wnt Signaling in Neurogenesis and Bipolar Disorder.

Authors:  Alexander J Valvezan; Peter S Klein
Journal:  Front Mol Neurosci       Date:  2012-01-30       Impact factor: 5.639
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.